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Introduction
The micro heterogeneity or quality of a protein has been
shown to have a significant impact on its physical, che-
mical and biological properties both in vitro and in vivo
[1]. Micro heterogeneity is evaluated in terms of post
translational modifications such as glycosylation, charge
variants, aggregates and fragments profile. The biggest
challenge in process development is to find a balance
between increasing productivity while maintaining pro-
duct quality.
In our study we focus on protein glycosylation, which
is a process in which oligosaccharides are added to the
protein during synthesis. There are multiple possible
reactions in the pathway and it takes a long time for a
glycosylated protein to be fully processed. If some pro-
tein molecules have a shorter residence time in the ER
and Golgi, the glycan may be only at an intermediate
stage [1]. For recombinant glycoprotein, increase in cell
specific productivity (amount of product produced per
cell per unit time) which may result in shorter residence
time in the ER and Golgi, must be weighed against pos-
sible changes in product quality attributes like glycosyla-
tion [2]. Our study concludes that it is possible to
produce a protein with desired product quality profile
with high specific productivity. Two different clones
with the same productivity can have different product
quality profiles; alternatively, the same clone with differ-
ent specific productivity can be manipulated to produce
the same desired product quality by altering the cell cul-
ture parameters or addition of supplements. This obser-
vation also influences the acknowledged methodology
for selecting clones with higher productivity while still
maintaining their product quality profile. Various
process manipulations were evaluated as an attempt to
improve on the product quality profiles without com-
promising the productivity.
Materials and methods
Three CHO cell lines (A, B & C) expressing three differ-
ent Antibodies (Ab1, Ab2 & Ab3) were cultured in com-
mercially available animal component free media in 125
ml Erlenmeyer shake flasks and BIOSTAT B-DCU lab
bioreactors. Cell Count and Viability were analyzed by
Cedex Hires (Innovatis) and heamocytometer using Try-
pan blue dye exclusion. The product concentration was
determined by Affinity chromatography and characteri-
zation (Glycan profiling) by Normal phase HPLC.
Results and discussion
Clone Selection program
Figure 1 shows the plot of N.PCD (normalized specific
productivity – picogram per cell per day) vs. N.GL %
(normalized values of one type of glycosylated species)
of different clones for the antibodies Ab1 & Ab3. Both
show a similar general trend indicating an increase in N.
GL (%) with increasing specific productivities. There are
however some exceptions where clones with significantly
different specific productivity show very similar glycosy-
lation profile, which suggest the role of process condi-
tions in affecting the product quality.
Case study 1: Ab1
As seen in (Figure 2a), the desired N. GL (%) for Ab1
was comparable to the product obtained from the high
PCD clones in Process 1. However, when the process
was run in a different reactor configuration, a decrease
in N.GL (%) was observed. Experiments were done to
understand the impact of changes in the reactor condi-
tions by varying the reactor dependent parameters* Correspondence: Dinesh.baskar@biocon.com
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(aeration, agitation etc) and the feeding strategy. These
results were used to modify the Process 2 and made as
a more robust Process 3. The Process 3 was able to give
a higher value of N.GL (%) while still retaining the high
PCD.
Case study 2: Ab2
All the high producing clones for Ab2 were giving sig-
nificantly higher N.GL (%) compared to the desired
quality. A study was conducted to evaluate the possibi-
lity of choosing the high producing clone and manipu-
late the glycan profiles to be able to meet the product
quality requirements. Intermittent samples were taken
from the Fed batch runs and analyzed for product conc.
and glycan profiles. Both PCD and N.GL (%) vary during
the course of the run with a general trend of higher N.
GL(%) with increase in PCD. However there were
exceptions like day 8 vs. day 12 where the PCD of day 8
was significantly lower than day 12 however the N.GL
(%) value was higher for the day 8. The feeding strategy
and the process parameters (controlled and measured)
around day 8 were estimated and compared to other
days.
The results of the investigation showed that a feed
added at around day 8 during the batch, helped in redu-
cing the N. GL (%) values. The quantity of this feed as
well as its feeding strategy were changed which helped
in getting the desired product quality. The results from
the study done above were implemented in the process.
Case study 3: Ab3
The desired N. GL (%) for the product was significantly
lower than the range obtained from most of the clones.
The process used here is referred to as Process A. Feed-
ing concepts implemented in the Ab2 improved process
were tested in the Ab3 which is referred as Process B.
The feed manipulations helped in bringing down the N.
GL (%) values. However they were still much higher
than the desired range. The time course analysis of the
Process B batches was done. The analysis indicated
Figure 1 Plot of N.PCD vs. N.GL % for Ab1 & Ab3 suggest that there are some clones which have very different PCDs but similar product
quality.
Figure 2 a: Profiles of Process 1, 2 & 3 for Ab1 Figure 2b: Profiles of Process A, B & C for Ab3
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some days during the run where the level of N.GL (%)
were much lower compared to other days. Detailed ana-
lysis of the culture conditions during these days was
done. The outcome of these analysis were implemented
in the process by changing the culture parameters dur-
ing the run. This process is referred as Process C. The
profiles of batches run with Processes A, B and C are
shown in (Figure 2b). Significant decrease in the level of
N. GL (%) was observed in Process C without affecting
the PCD of the cells.
Conclusion
It was generally observed that the clones with high spe-
cific productivity also have high levels of N.GL (%).
Since some of the products required lower levels of N.
GL (%); these high producing clones were found to be
unsuitable. However, the results of this study show that
with modified conditions of process parameters and
feeding strategies, it was possible to alter the N.GL (%)
levels without impacting the cell line specific productiv-
ity. These factors when taken into consideration during
clone selection may still allow the selection of high pro-
ducing clones with a possibility to alter the product pro-
files during development.
Acknowledgement
Cell Culture group: Chandrashekhar Kuruvangi, Janani Kanakrajan, Rohit
Diwakar
Published: 22 November 2011
References
1. Hu WS, Betenbough M: Technology for Secretory Therapeutic Proteins.
Cellular Bioprocess technology; 2007.
2. Hossler P, Khattak SF, Li Zheng: Optimal and consistent protein
glycosylation in mammalian cell culture. Glycobiology 2009, 19(9):936-949.
doi:10.1186/1753-6561-5-S8-P95
Cite this article as: Srivastava et al.: Influence of cell specific productivity
on product quality. BMC Proceedings 2011 5(Suppl 8):P95.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Srivastava et al. BMC Proceedings 2011, 5(Suppl 8):P95
http://www.biomedcentral.com/1753-6561/5/S8/P95
Page 3 of 3
